Immix Biopharma, Inc. IMMX
NASDAQ · United States · Health Technology
$10.18-0.22 (-2.16%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-07 | -0.18 | -0.17 | -5.0% | $0 | — | +0.7%$10.06→$10.13 |
| Q1 2026 | 2026-05-07 | -0.18 | -0.21 | +14.3% | — | — | -5.5%$10.32→$9.75 |
| Q4 2025 | 2026-03-25 | -0.28 | -0.16 | -75.0% | — | — | +1.8%$8.57→$8.72 |
| Q3 2025 | 2025-11-07 | -0.24 | -0.19 | -26.3% | — | — | +6.9%$3.03→$3.24 |
| Q2 2025 | 2025-08-08 | -0.22 | -0.16 | -37.5% | — | — | — |
| Q1 2025 | 2025-05-08 | -0.15 | -0.23 | +34.8% | — | — | — |
| Q4 2024 | 2025-03-25 | -0.15 | -0.25 | +40.0% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.24 | -0.16 | -50.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.